IL310123A - Method for producing arylamide derivative - Google Patents
Method for producing arylamide derivativeInfo
- Publication number
- IL310123A IL310123A IL310123A IL31012324A IL310123A IL 310123 A IL310123 A IL 310123A IL 310123 A IL310123 A IL 310123A IL 31012324 A IL31012324 A IL 31012324A IL 310123 A IL310123 A IL 310123A
- Authority
- IL
- Israel
- Prior art keywords
- compound
- group
- methyl
- mmol
- fluoro
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/76—Nitrogen atoms to which a second hetero atom is attached
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4436—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/22—Organic complexes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/24—Phosphines, i.e. phosphorus bonded to only carbon atoms, or to both carbon and hydrogen atoms, including e.g. sp2-hybridised phosphorus compounds such as phosphabenzene, phosphole or anionic phospholide ligands
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B61/00—Other general methods
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/66—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Inorganic Chemistry (AREA)
- Materials Engineering (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021120977 | 2021-07-21 | ||
| PCT/JP2022/028187 WO2023003014A1 (ja) | 2021-07-21 | 2022-07-20 | アリールアミド誘導体の製造方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL310123A true IL310123A (en) | 2024-03-01 |
Family
ID=84980009
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL310123A IL310123A (en) | 2021-07-21 | 2022-07-20 | Method for producing arylamide derivative |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20240327355A1 (enExample) |
| EP (1) | EP4375273A4 (enExample) |
| JP (2) | JP7268255B1 (enExample) |
| KR (1) | KR102671612B1 (enExample) |
| CN (1) | CN117677607A (enExample) |
| AR (1) | AR126517A1 (enExample) |
| AU (1) | AU2022312992A1 (enExample) |
| CA (1) | CA3226827A1 (enExample) |
| IL (1) | IL310123A (enExample) |
| MX (1) | MX2024000908A (enExample) |
| TW (1) | TW202321198A (enExample) |
| WO (1) | WO2023003014A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025007811A1 (zh) * | 2023-07-06 | 2025-01-09 | 成都华健未来科技有限公司 | 一类芳香酰胺类衍生物及其用途 |
| WO2025146040A1 (zh) * | 2024-01-01 | 2025-07-10 | 华健未来(成都)科技股份有限公司 | 芳香酰肼类衍生物及其医药用途 |
| CN118604164B (zh) * | 2024-05-15 | 2025-06-06 | 石家庄四药有限公司 | 一种非奈利酮中间体中杂质的检测方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8084645B2 (en) * | 2003-09-19 | 2011-12-27 | Chugai Seiyaku Kabushiki Kaisha | 4-phenylamino-benzaldoxime derivatives and uses thereof as mitogen-activated protein kinase kinase (MEK) inhibitors |
| MY144232A (en) | 2004-07-26 | 2011-08-15 | Chugai Pharmaceutical Co Ltd | 5-substituted-2-phenylamino benzamides as mek inhibitors |
| AR059339A1 (es) | 2006-02-09 | 2008-03-26 | Chugai Pharmaceutical Co Ltd | Derivados de la cumarina para trastornos proliferativos de celulas, composicion farmaceutica y agente terapeutico que los contiene |
| JP2016034900A (ja) * | 2012-11-26 | 2016-03-17 | 中外製薬株式会社 | 5−置換−2−フェニルアミノ−ベンズアミド類の製造方法 |
| AR121078A1 (es) * | 2020-01-22 | 2022-04-13 | Chugai Pharmaceutical Co Ltd | Derivados de arilamida con actividad antitumoral |
| JPWO2022018875A1 (enExample) * | 2020-07-22 | 2022-01-27 | ||
| WO2022019329A1 (ja) * | 2020-07-22 | 2022-01-27 | 中外製薬株式会社 | アリールアミド誘導体を含む組成物 |
-
2022
- 2022-07-20 JP JP2022563493A patent/JP7268255B1/ja active Active
- 2022-07-20 AR ARP220101914A patent/AR126517A1/es unknown
- 2022-07-20 CN CN202280050524.4A patent/CN117677607A/zh active Pending
- 2022-07-20 IL IL310123A patent/IL310123A/en unknown
- 2022-07-20 US US18/579,949 patent/US20240327355A1/en active Pending
- 2022-07-20 TW TW111127162A patent/TW202321198A/zh unknown
- 2022-07-20 AU AU2022312992A patent/AU2022312992A1/en active Pending
- 2022-07-20 WO PCT/JP2022/028187 patent/WO2023003014A1/ja not_active Ceased
- 2022-07-20 MX MX2024000908A patent/MX2024000908A/es unknown
- 2022-07-20 EP EP22845947.5A patent/EP4375273A4/en active Pending
- 2022-07-20 CA CA3226827A patent/CA3226827A1/en active Pending
- 2022-07-20 KR KR1020237036428A patent/KR102671612B1/ko active Active
-
2023
- 2023-04-20 JP JP2023069597A patent/JP2023084138A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20230152797A (ko) | 2023-11-03 |
| KR102671612B1 (ko) | 2024-05-31 |
| TW202321198A (zh) | 2023-06-01 |
| US20240327355A1 (en) | 2024-10-03 |
| AR126517A1 (es) | 2023-10-18 |
| CA3226827A1 (en) | 2023-01-26 |
| EP4375273A4 (en) | 2025-05-21 |
| CN117677607A (zh) | 2024-03-08 |
| JPWO2023003014A1 (enExample) | 2023-01-26 |
| WO2023003014A1 (ja) | 2023-01-26 |
| JP7268255B1 (ja) | 2023-05-02 |
| AU2022312992A1 (en) | 2024-02-29 |
| EP4375273A1 (en) | 2024-05-29 |
| JP2023084138A (ja) | 2023-06-16 |
| MX2024000908A (es) | 2024-02-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL294916A (en) | An arylamide derivative with antitumor activity | |
| IL300051A (en) | The composition containing an arylamide derivative | |
| IL310123A (en) | Method for producing arylamide derivative | |
| JP7168734B2 (ja) | アリールアミド誘導体を含む細胞増殖性疾患の治療又は予防用医薬組成物 | |
| TW202344504A (zh) | Lpa受體拮抗劑及其用途 | |
| JP5978302B2 (ja) | リゾホスファチジン酸アンタゴニストとしての(n−ベンズイミダゾール−2−イル)−シクロプロパンカルボキサミド | |
| TW201806593A (zh) | 含有ep拮抗藥與免疫核查點阻礙藥而成之組合 | |
| CA3106733A1 (en) | Sulfoximine compound as bromodomain protein inhibitor and pharmaceutical composition and medical use thereof | |
| AU2020332462B2 (en) | Azaheteroaryl compound and application thereof | |
| EA050002B1 (ru) | Способ получения производного ариламида | |
| TW202408495A (zh) | Jak激酶抑制劑的前藥 | |
| HK40084009A (en) | Composition containing arylamide derivative | |
| EA047579B1 (ru) | Производное ариламида, обладающее противоопухолевой активностью |